Connection

Jean-Charles Soria to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about TOR Serine-Threonine Kinases.
Jean-Charles Soria
Connection Strength
0.199
TOR Serine-Threonine Kinases
  1. Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors. J Clin Oncol. 2014 Jan 10; 32(2):68-75.
    View in: PubMed
    Score: 0.109
  2. Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues. Eur J Cancer. 2011 Oct; 47(15):2249-55.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.